ArticleAnimal models and experimental medicine2026
Comparative analysis of TP53 gene in Tupaia belangeri subspecies (Tupaia belangeri yaoshanensis vs. Tupaia belangeri chinensis) and identification of mutations in spontaneous tumor cases.
Article in Animal models and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The tree shrew (Tupaia belangeri) is an emerging animal model for human diseases, yet the status of the critical tumor suppressor TP53 in its subspecies and spontaneous tumors is unknown. We sequenced the entire TP53 coding region from two subspecies, T. b. yaoshanensis and T. b. chinensis, and analyzed two spontaneous sarcomas from T. b. yaoshanensis using histopathology, immunohistochemistry, and cDNA sequencing with clonal validation. TP53 showed 99.5% nucleotide identity between subspecies, with a single fixed non-synonymous substitution (D42G) in T. b. yaoshanensis predicted to be functionally neutral. All residues corresponding to human cancer hotspots were strictly conserved, and structural modeling confirmed high similarity to human p53 (RMSD = 0.6 Å). Critically, we identified TP53 sequence variants in both spontaneous tumors: a missense variant (Ser175Gly) in the DNA-binding domain of a liposarcoma and another (Met344Thr) in the tetramerization domain of a myxofibrosarcoma. Computational prediction suggested both missense variants are tolerated (SIFT scores 0.61 and 0.77), and their functional significance remains to be determined. This study provides preliminary evidence of TP53 variants in spontaneous tree shrew tumors and reveals natural subspecies variation. The high conservation of p53 reinforces the tree shrew's relevance as a model for TP53-related cancer research, although further functional studies are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.